RxSight, Inc. - Common Stock (RXST)
8.0000
-0.4600 (-5.44%)
NASDAQ · Last Trade: Jul 12th, 3:19 AM EDT
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · July 9, 2025
Via Benzinga · July 9, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · July 9, 2025
Via Benzinga · July 9, 2025
Via Benzinga · July 9, 2025
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · July 9, 2025
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · July 9, 2025
Via Benzinga · July 9, 2025
Via Benzinga · July 9, 2025
Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover interest.
Via Benzinga · July 9, 2025
RxSight Inc. (RXST) shares plunged 34.32% in after-hours. The decline to $8.40 follows a downward revision of its 2025 revenue forecast.
Via Benzinga · July 9, 2025
Via Benzinga · July 8, 2025
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · July 8, 2025
Let's have a look at what is happening on the US markets on Monday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · May 19, 2025
Via Benzinga · May 19, 2025
Via Benzinga · May 9, 2025
Via Benzinga · April 15, 2025
Via Benzinga · April 4, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via Chartmill · April 3, 2025
RxSight revised its FY25 revenue outlook below estimates, with Q1 sales lagging expectations. BofA downgraded the stock, citing slowing growth and risks ahead.
Via Benzinga · April 3, 2025
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · April 3, 2025
Via Benzinga · April 3, 2025